Mad2 expression levels with chromosomal abnormalities can be a biomarker for esophageal cancer

A new research paper was published in Oncotarget's Volume 15 on February 5, 2024, entitled, "Differential expression of Mad2 gene is consequential to the patterns of histone H3 post-translational modifications in its promoter region in human esophageal cancer samples."

Related Keywords

,Sillarine Kurkalang ,Pooja Swargiary ,Hughbert Dakhar ,Nabamita Boruah ,Chongtham Sovachandra Singh ,Atanu Banerjee ,Anupam Chatterjee ,North Eastern Hill University ,Assam Royal Global University ,Ln Mithila University ,University Of Chicago Medicine ,University Of Pennsylvania ,Chicago Medicine ,Nazareth Hospital ,Cancer ,Esophageal Cancer ,Gene ,Ncology ,Phosphorylation ,Promoter ,Promoter Region ,Protein ,Research ,Humor ,